Pandey; Niranjan B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pandey; Niranjan B..The latest application filed is for "mimetic peptides derived from collagen type iv and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases".

Company Profile

4.11.17

Pandey; Niranjan B. - White Marsh MD
Pandey; Niranjan B. - Baltimore MD
Pandey; Niranjan B. - Flemington NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases Grant 11,155,603 - Popel , et al. October 26, 2	2021-10-26
Biomimetic Peptide And Biodegradable Delivery Platform For The Treatment Of Angiogenesis- And Lymphangiogenesis-dependent Diseases App 20200361993 - POPEL; ALEKSANDER S. ; et al.	2020-11-19
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphangiogenesis- Dependent Diseases App 20200362017 - POPEL; ALEKSANDER S. ; et al.	2020-11-19
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases Grant 10,774,131 - Popel , et al. Sept	2020-09-15
Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases Grant 10,774,112 - Popel , et al. Sept	2020-09-15
Compounds And Methods For Activating Tie2 Signaling App 20190225670 - Pandey; Niranjan B. ; et al.	2019-07-25
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphangiogenesis- Dependent Diseases App 20190002531 - POPEL; ALEKSANDER S. ; et al.	2019-01-03
Peptides With Anti-angiogenic, Anti-lymphangiogenic, And Anti-edemic Properties And Nanoparticle Formulations App 20180339024 - BRESSLER; Eric M. ; et al.	2018-11-29
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases Grant 10,106,597 - Popel , et al. October 23, 2	2018-10-23
Biomimetic Peptide And Biodegradable Delivery Platform For The Treatment Of Angiogenesis- And Lymphangiogenesis-dependent Diseases App 20180134753 - POPEL; ALEKSANDER S. ; et al.	2018-05-17
Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases Grant 9,802,984 - Popel , et al. October 31, 2	2017-10-31
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphangiogenesis- Dependent Diseases App 20170174749 - POPEL; ALEKSANDER S. ; et al.	2017-06-22
A Biomimetic Peptide And Biodegradable Delivery Platform For The Treatment Of Angiogenesis- And Lymphangiogenesis-dependent Diseases App 20160122390 - POPEL; ALEKSANDER S. ; et al.	2016-05-05
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphangiogenesis- Dependent Diseases App 20150307592 - POPEL; ALEKSANDER S. ; et al.	2015-10-29
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases Grant 9,056,923 - Popel , et al. June 16, 2	2015-06-16
Mimetic Peptides Derived From Collagen Type Iv And Their Use For Treating Angiogenesis- And Lymphagiogenesis-dependent Diseases App 20130316950 - Popel; Aleksander S. ; et al.	2013-11-28
Thiazolopyridine kinase inhibitors Grant 7,659,284 - Connolly , et al. February 9, 2	2010-02-09
Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors Grant 7,605,154 - Binnun , et al. October 20, 2	2009-10-20
Thia-tetraazaacenaphthylene kinase inhibitors Grant 7,579,356 - Battista , et al. August 25, 2	2009-08-25
Substituted Thiatriazaacenaphthylene-6-carbonitrile Kinase Inhibitors App 20080300264 - Connolly; Peter J. ; et al.	2008-12-04
Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors Grant 7,427,625 - Connolly , et al. September 23, 2	2008-09-23
Substituted Thienopyrimidine Kinase Inhibitors App 20080108611 - Battista; Kathleen A. ; et al.	2008-05-08
Thia-tetraazaacenaphthylene kinase inhibitors App 20070265264 - Battista; Kathleen A. ; et al.	2007-11-15
Substituted Thiatriazaacenaphthylene-6-carbonitrile Kinase Inhibitors App 20070225309 - Connolly; Peter J. ; et al.	2007-09-27
Thiazolopyrimidine kinase inhibitors App 20070185139 - Binnun; Eva ; et al.	2007-08-09
Thiazolopyridine kinase inhibitors App 20060058341 - Connolly; Peter J. ; et al.	2006-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.